Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
extended-release
Pharma
Amneal's new Parkinson's drug passes muster with US regulators
As multiple drugmakers race to bring new levodopa-based Parkinson’s treatments to the market, New Jersey’s Amneal has taken home the gold in the U.S.
Fraiser Kansteiner
Aug 8, 2024 3:26am
Rovi wins FDA nod to make Moderna's COVID shot at Spanish plant
Feb 28, 2024 11:22am
Teva taps Royalty to bankroll long-acting schizophrenia drug
Nov 13, 2023 11:40am
FDA shoots down Amneal's Parkinson's med
Jul 5, 2023 11:08am
FDA rejects Incyte's Jakafi XR, hurting pipeline hopes: analyst
Mar 24, 2023 11:05am
Teva takes 2nd long-acting schizophrenia drug into phase 3
Jan 31, 2023 7:10am
